Skip to main content
Top
Published in: Sleep and Breathing 2/2021

Open Access 01-06-2021 | Sleep Apnea | Basic Science • Original Article

The effect of intermittent hypoxia and fecal microbiota of OSAS on genes associated with colorectal cancer

Authors: Jia Gao, Hailong Cao, Qiang Zhang, Bangmao Wang

Published in: Sleep and Breathing | Issue 2/2021

Login to get access

Abstract

Purpose

Colorectal cancer (CRC) is one of the common causes of cancer death worldwide. Obstructive sleep apnea syndrome (OSAS), sharing many risk factors in common with CRC, is prevalent among CRC patients. OSAS may promote the CRC development independently but the mechanism is still unknown. Intermittent hypoxia (IH) is one of the characteristics of OSAS, and hypoxia may influence the genes associated with CRC. Intestinal microbiota plays important role in CRC carcinogenesis, and OSAS patients have been shown to have intestinal microbiota dysbiosis. We hypothesized that IH and intestinal microbiota dysbiosis may be involved for CRC in patients with OSAS.

Methods

We established precancerous cell models of CRC with Immorto-Min colonic epithelial (IMCE) cells. First, the cells were exposed to IH in a special chamber for 4 h, 8 h, and 12 h. Feces from 6 patients with OSAS and 6 healthy controls were collected and made into sterile fecal fluid for incubation with IMCE cells for 12 h. The cells were then exposed to IH for 4 h, 8 h, and 12 h. After IH exposure, the expressions of genes and inflammation cytokines associated with CRC, such as β-catenin, STAT3, HIF-1α, IL-6, TNF-α, c-myc, and cyclinD1, were tested.

Results

IH activated the expression of HIF-1α and STAT3 both in mRNA and protein level (HIF-1α: P = 0.015 for mRNA level, P = 0.027 for protein level; STAT3: P = 0.023 for mRNA level, P = 0.023 for protein level), and promoted p-STAT3 shifting to the nucleus (P = 0.023). The mRNA of β-catenin (P = 0.022) and cyclinD1 (P = 0.023) was elevated, but there was no change for the β-catenin protein in the nucleus. Gut microbiota of OSAS patients promoted the expression of STAT3 (protein level: 0 h: P = 0.037; 4 h: P = 0.046; 8 h: P = 0.049; 12 h: P = 0.037), promoted p-STAT3 (4 h: P = 0.049; 8 h: P = 0.046; 12 h: P = 0.046) shifting to the nucleus, and also elevated the expression of IL-6 and TNF-α in mRNA level at 4 h (IL-6: P = 0.037, TNF-α: P = 0.037) and 8 h (IL-6: P = 0.037, TNF-α: P = 0.037). The protein of β-catenin in the nucleus was not affected by IH and gut microbiota from OSAS.

Conclusions

Our study demonstrated that IH and gut microbiota of patients with OSAS activated HIF-1α expression and STAT3 pathway in IMCE cells, with no influence on β-catenin pathway, which suggested that IH, STAT3 pathway, chronic inflammation, and intestinal microbiota dysbiosis may be involved in CRC carcinogenesis correlated with OSAS These findings must be interpreted cautiously and further research is necessary to clarify the causative steps in CRC development.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424CrossRefPubMed
3.
go back to reference Song M, Chan AT, Sun J (2019) Influence of the Gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology. Song M, Chan AT, Sun J (2019) Influence of the Gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology.
4.
go back to reference Desai D, Shah S, Deshmukh A et al (2015) Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer. World J Gastroenterol 21(12):3644–3649PubMedPubMedCentral Desai D, Shah S, Deshmukh A et al (2015) Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer. World J Gastroenterol 21(12):3644–3649PubMedPubMedCentral
5.
go back to reference Claesson M, Fagerlund MJ, Haapamaki M et al (2006) Sleep apnea is prevalent among patients scheduled for surgery of colorectal cancer. Eur J Surg Oncol 42(9):s148 Claesson M, Fagerlund MJ, Haapamaki M et al (2006) Sleep apnea is prevalent among patients scheduled for surgery of colorectal cancer. Eur J Surg Oncol 42(9):s148
6.
go back to reference Lévy P, Tamisier R, Minville C, Launois S, Pépin JL (2011) Sleep apnoea syndrome in 2011: current concepts and future directions. Eur Respir Rev 20(121):134–146PubMed Lévy P, Tamisier R, Minville C, Launois S, Pépin JL (2011) Sleep apnoea syndrome in 2011: current concepts and future directions. Eur Respir Rev 20(121):134–146PubMed
8.
go back to reference Jean-Louis G, Zizi F, Clark LT, Brown CD, McFarlane SI (2008) Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med 4(3):261–272PubMedPubMedCentral Jean-Louis G, Zizi F, Clark LT, Brown CD, McFarlane SI (2008) Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med 4(3):261–272PubMedPubMedCentral
9.
10.
go back to reference Hung J, Whitford EG, Parsons RW, Hillman DR (1990) Association of sleep apnoea with myocardial infarction in men. Lancet. 336(8710):261–264PubMed Hung J, Whitford EG, Parsons RW, Hillman DR (1990) Association of sleep apnoea with myocardial infarction in men. Lancet. 336(8710):261–264PubMed
11.
go back to reference Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2341PubMed Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2341PubMed
12.
go back to reference Pedrosa RP, Drager LF, Gonzaga CC et al (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 58(5):811–817PubMed Pedrosa RP, Drager LF, Gonzaga CC et al (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 58(5):811–817PubMed
13.
go back to reference Tasali E, Mokhlesi B, Van Cauter E (2008) Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 133(2):496–506PubMed Tasali E, Mokhlesi B, Van Cauter E (2008) Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 133(2):496–506PubMed
14.
go back to reference Chen YH, Keller JK, Kang JH, Hsieh HJ, Lin HC (2013) Obstructive sleep apnea and the subsequent risk of depressive disorder: a population-based follow-up study. J Clin Sleep Med 9(5):417–423PubMedPubMedCentral Chen YH, Keller JK, Kang JH, Hsieh HJ, Lin HC (2013) Obstructive sleep apnea and the subsequent risk of depressive disorder: a population-based follow-up study. J Clin Sleep Med 9(5):417–423PubMedPubMedCentral
15.
go back to reference Campos-Rodriguez F, Martinez-Garcia MA, Martinez M et al (2013) Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med 187(1):99–105PubMed Campos-Rodriguez F, Martinez-Garcia MA, Martinez M et al (2013) Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med 187(1):99–105PubMed
16.
go back to reference Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9(3):211–224PubMed Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9(3):211–224PubMed
17.
go back to reference Sillah A, Watson NF, Schwartz SM, Gozal D, Phipps AI (2018) Sleep apnea and subsequent cancer incidence. Cancer Causes Control 29(10):987–994PubMedPubMedCentral Sillah A, Watson NF, Schwartz SM, Gozal D, Phipps AI (2018) Sleep apnea and subsequent cancer incidence. Cancer Causes Control 29(10):987–994PubMedPubMedCentral
18.
go back to reference Brenner R, Kivity S, Peker M et al (2019) Increased risk for cancer in young patients with severe obstructive sleep apnea. Respiration. 97(1):15–23PubMed Brenner R, Kivity S, Peker M et al (2019) Increased risk for cancer in young patients with severe obstructive sleep apnea. Respiration. 97(1):15–23PubMed
19.
go back to reference Martínez-García MÁ, Campos-Rodriguez F, Barbé F (2016) Cancer and OSA: current evidence from human studies. Chest. 150(2):451–463PubMed Martínez-García MÁ, Campos-Rodriguez F, Barbé F (2016) Cancer and OSA: current evidence from human studies. Chest. 150(2):451–463PubMed
20.
go back to reference Pérez-Warnisher MT, Cabezas E, Troncoso MF et al (2019) Sleep disordered breathing and nocturnal hypoxemia are very prevalent in a lung cancer screening population and may condition lung cancer screening findings: results of the prospective Sleep Apnea In Lung Cancer Screening (SAILS) study. Sleep Med 54:181–186PubMed Pérez-Warnisher MT, Cabezas E, Troncoso MF et al (2019) Sleep disordered breathing and nocturnal hypoxemia are very prevalent in a lung cancer screening population and may condition lung cancer screening findings: results of the prospective Sleep Apnea In Lung Cancer Screening (SAILS) study. Sleep Med 54:181–186PubMed
21.
go back to reference Cabezas E, Pérez-Warnisher MT, Troncoso MF et al (2019) Sleep disordered breathing is highly prevalent in patients with lung cancer: results of the sleep apnea in lung cancer study. Respiration. 97(2):119–124PubMed Cabezas E, Pérez-Warnisher MT, Troncoso MF et al (2019) Sleep disordered breathing is highly prevalent in patients with lung cancer: results of the sleep apnea in lung cancer study. Respiration. 97(2):119–124PubMed
22.
go back to reference Brenner R, Kivity S, Peker M et al (2018) Increased risk for cancer in young patients with severe obstructive sleep apnea. Respiration.:1–9 Brenner R, Kivity S, Peker M et al (2018) Increased risk for cancer in young patients with severe obstructive sleep apnea. Respiration.:1–9
23.
go back to reference Zhang X, Giovannucci EL, Wu K et al (2013) Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep. 36(5):681–688PubMedPubMedCentral Zhang X, Giovannucci EL, Wu K et al (2013) Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep. 36(5):681–688PubMedPubMedCentral
24.
go back to reference Lee S, Kim BG, Kim JW et al (2017) Obstructive sleep apnea is associated with an increased risk of colorectal neoplasia. Gastrointest Endosc 85(3):568–573.e1PubMed Lee S, Kim BG, Kim JW et al (2017) Obstructive sleep apnea is associated with an increased risk of colorectal neoplasia. Gastrointest Endosc 85(3):568–573.e1PubMed
25.
go back to reference Li H, Rokavec M, Jiang L, Horst D, Hermeking H (2017) Antagonistic effects of p53 and HIF1A on microRNA-34a regulation of PPP1R11 and STAT3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells. Gastroenterology 153(2):505–520PubMed Li H, Rokavec M, Jiang L, Horst D, Hermeking H (2017) Antagonistic effects of p53 and HIF1A on microRNA-34a regulation of PPP1R11 and STAT3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells. Gastroenterology 153(2):505–520PubMed
26.
go back to reference Nagaraju GP, Bramhachari PV, Raghu G, El-Rayes BF (2015) Hypoxia inducible factor-1α: its role in colorectal carcinogenesis and metastasis. Cancer Lett 366(1):11–18PubMed Nagaraju GP, Bramhachari PV, Raghu G, El-Rayes BF (2015) Hypoxia inducible factor-1α: its role in colorectal carcinogenesis and metastasis. Cancer Lett 366(1):11–18PubMed
27.
go back to reference Yu S, Zhou R, Yang T et al (2019) Hypoxia promotes colorectal cancer cell migration and invasion in a SIRT1-dependent manner. Cancer Cell Int 19:116PubMedPubMedCentral Yu S, Zhou R, Yang T et al (2019) Hypoxia promotes colorectal cancer cell migration and invasion in a SIRT1-dependent manner. Cancer Cell Int 19:116PubMedPubMedCentral
34.
go back to reference Ko CY, Liu QQ, Su HZ et al (2019) Gut microbiota in obstructive sleep apnea-hypopnea syndrome: disease-related dysbiosis and metabolic comorbidities. Clin Sci (Lond) 133(7):905–917 Ko CY, Liu QQ, Su HZ et al (2019) Gut microbiota in obstructive sleep apnea-hypopnea syndrome: disease-related dysbiosis and metabolic comorbidities. Clin Sci (Lond) 133(7):905–917
37.
go back to reference Jing F, Baoyuan C, Meinan G et al (2006) A noveI system for the simulation of various intermittent hypoxia modes. J Tianjin Med Univ 12(4):509–512 Jing F, Baoyuan C, Meinan G et al (2006) A noveI system for the simulation of various intermittent hypoxia modes. J Tianjin Med Univ 12(4):509–512
38.
go back to reference Liu ZK, Chen BY, Feng J et al (2011) The effect of intermittent hypoxia with different degrees and frequencies on levels of superoxide dismutases and malondialdehyde in vascular endothelial cells. Zhonghua Jie He He Hu Xi Za Zhi 34(5):371–374PubMed Liu ZK, Chen BY, Feng J et al (2011) The effect of intermittent hypoxia with different degrees and frequencies on levels of superoxide dismutases and malondialdehyde in vascular endothelial cells. Zhonghua Jie He He Hu Xi Za Zhi 34(5):371–374PubMed
39.
go back to reference Feng J, Chen BY, Guo MN et al (2007) Changes of nuclear factor-kappaB and intercellular adhesion molecule-1 in endothelial cells exposed to various intermittent hypoxia. Zhonghua Jie He He Hu Xi Za Zhi 30(3):202–206PubMed Feng J, Chen BY, Guo MN et al (2007) Changes of nuclear factor-kappaB and intercellular adhesion molecule-1 in endothelial cells exposed to various intermittent hypoxia. Zhonghua Jie He He Hu Xi Za Zhi 30(3):202–206PubMed
40.
go back to reference Li YM, Chen BY, Feng J et al (2010) Effect of different intermittent hypoxia patterns on interleukin-6 and interleukin-8 levels of human umbilical vein endothelial cells. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 45(2):139–142PubMed Li YM, Chen BY, Feng J et al (2010) Effect of different intermittent hypoxia patterns on interleukin-6 and interleukin-8 levels of human umbilical vein endothelial cells. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 45(2):139–142PubMed
43.
go back to reference Xin L, Fan W, Tingting D, Zuoming S, Qiang Z (2019) 4-phenylbutyric acid attenuates endoplasmic reticulum stress-mediated apoptosis and protects the hepatocytes from intermittent hypoxia-induced injury. Sleep Breath 23(2):711–717PubMed Xin L, Fan W, Tingting D, Zuoming S, Qiang Z (2019) 4-phenylbutyric acid attenuates endoplasmic reticulum stress-mediated apoptosis and protects the hepatocytes from intermittent hypoxia-induced injury. Sleep Breath 23(2):711–717PubMed
44.
go back to reference Mengque X. (2016) Study of deoxycholic acid-mediated-gut dysbiosis induced intestinal adenoma-adenocarcinoma sequence. In: Bangmao W, editor. Internal medicine of digestive diseases. Tianjin Mengque X. (2016) Study of deoxycholic acid-mediated-gut dysbiosis induced intestinal adenoma-adenocarcinoma sequence. In: Bangmao W, editor. Internal medicine of digestive diseases. Tianjin
46.
go back to reference Xiang L (2018) Dysbiosis contributes to chronic constipation development in the intestine. In: Kui J, editor. Internal medicine of digestive diseases. Tianjin Xiang L (2018) Dysbiosis contributes to chronic constipation development in the intestine. In: Kui J, editor. Internal medicine of digestive diseases. Tianjin
57.
go back to reference Liu LX, Lu H, Luo Y et al (2002) Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem Biophys Res Commun 291(4):908–914PubMed Liu LX, Lu H, Luo Y et al (2002) Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem Biophys Res Commun 291(4):908–914PubMed
58.
go back to reference Semenza GL (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33(4):207–214PubMedPubMedCentral Semenza GL (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33(4):207–214PubMedPubMedCentral
59.
go back to reference Semenza GL (2013) HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 123(9):3664–3671PubMedPubMedCentral Semenza GL (2013) HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 123(9):3664–3671PubMedPubMedCentral
60.
go back to reference Xue X, Shah YM (2013) Hypoxia-inducible factor-2α is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer. Carcinogenesis. 34(1):163–169PubMed Xue X, Shah YM (2013) Hypoxia-inducible factor-2α is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer. Carcinogenesis. 34(1):163–169PubMed
61.
go back to reference Santoyo-Ramos P, Likhatcheva M, García-Zepeda EA, Castañeda-Patlán MC, Robles-Flores M (2014) Hypoxia-inducible factors modulate the stemness and malignancy of colon cancer cells by playing opposite roles in canonical Wnt signaling. PLoS One 9(11):e112580PubMedPubMedCentral Santoyo-Ramos P, Likhatcheva M, García-Zepeda EA, Castañeda-Patlán MC, Robles-Flores M (2014) Hypoxia-inducible factors modulate the stemness and malignancy of colon cancer cells by playing opposite roles in canonical Wnt signaling. PLoS One 9(11):e112580PubMedPubMedCentral
62.
go back to reference Krishnamachary B, Zagzag D, Nagasawa H et al (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66(5):2725–2731PubMed Krishnamachary B, Zagzag D, Nagasawa H et al (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66(5):2725–2731PubMed
63.
go back to reference To SK, Zeng WJ, Zeng JZ, Wong AS (2014) Hypoxia triggers a Nur77-β-catenin feed-forward loop to promote the invasive growth of colon cancer cells. Br J Cancer 110(4):935–945PubMedPubMedCentral To SK, Zeng WJ, Zeng JZ, Wong AS (2014) Hypoxia triggers a Nur77-β-catenin feed-forward loop to promote the invasive growth of colon cancer cells. Br J Cancer 110(4):935–945PubMedPubMedCentral
64.
go back to reference Baba Y, Nosho K, Shima K et al (2010) HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol 176(5):2292–2301PubMedPubMedCentral Baba Y, Nosho K, Shima K et al (2010) HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol 176(5):2292–2301PubMedPubMedCentral
65.
go back to reference Liu M, Du K, Fu Z, Zhang S, Wu X (2015) Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions. Med Oncol 32(1):394PubMed Liu M, Du K, Fu Z, Zhang S, Wu X (2015) Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions. Med Oncol 32(1):394PubMed
66.
go back to reference Ma X, Zhang H, Xue X, Shah YM (2017) Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity. J Biol Chem 292(41):17046–17056PubMedPubMedCentral Ma X, Zhang H, Xue X, Shah YM (2017) Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity. J Biol Chem 292(41):17046–17056PubMedPubMedCentral
67.
go back to reference Dang DT, Chen F, Gardner LB et al (2006) Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 66(3):1684–1936PubMed Dang DT, Chen F, Gardner LB et al (2006) Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 66(3):1684–1936PubMed
68.
go back to reference Lavie L (2003) Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7(1):35–51PubMed Lavie L (2003) Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7(1):35–51PubMed
69.
go back to reference Goodday RH, Bourque SE, Edwards PB (2016) Objective and subjective outcomes following maxillomandibular advancement surgery for treatment of patients with extremely severe obstructive sleep apnea (Apnea-Hypopnea Index >100). J Oral Maxillofac Surg 74(3):583–589PubMed Goodday RH, Bourque SE, Edwards PB (2016) Objective and subjective outcomes following maxillomandibular advancement surgery for treatment of patients with extremely severe obstructive sleep apnea (Apnea-Hypopnea Index >100). J Oral Maxillofac Surg 74(3):583–589PubMed
70.
go back to reference Martinez CA, Kerr B, Jin C, Cistulli PA, Cook KM (2019) Obstructive sleep apnea activates HIF-1 in a hypoxia dose-dependent manner in HCT116 colorectal carcinoma cells. Int J Mol Sci 20(2) Martinez CA, Kerr B, Jin C, Cistulli PA, Cook KM (2019) Obstructive sleep apnea activates HIF-1 in a hypoxia dose-dependent manner in HCT116 colorectal carcinoma cells. Int J Mol Sci 20(2)
81.
go back to reference Vadde R, Vemula S, Jinka R, Merchant N, Bramhachari PV, Nagaraju GP (2017) Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer. Crit Rev Oncol Hematol 113:22–27PubMed Vadde R, Vemula S, Jinka R, Merchant N, Bramhachari PV, Nagaraju GP (2017) Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer. Crit Rev Oncol Hematol 113:22–27PubMed
82.
go back to reference Qiu YY, Hu SJ, Bao YJ et al (2015) Anti-angiogenic and anti-proliferative effects of inhibition of HIF-1α by p-HIF-1α RNAi in colorectal cancer. Int J Clin Exp Pathol 8(7):7913–7920PubMedPubMedCentral Qiu YY, Hu SJ, Bao YJ et al (2015) Anti-angiogenic and anti-proliferative effects of inhibition of HIF-1α by p-HIF-1α RNAi in colorectal cancer. Int J Clin Exp Pathol 8(7):7913–7920PubMedPubMedCentral
83.
go back to reference Newton IP, Kenneth NS, Appleton PL, Näthke I, Rocha S (2010) Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection. Mol Biol Cell 21(21):3630–3638PubMedPubMedCentral Newton IP, Kenneth NS, Appleton PL, Näthke I, Rocha S (2010) Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection. Mol Biol Cell 21(21):3630–3638PubMedPubMedCentral
84.
go back to reference Xue X, Jungles K, Onder G, Samhoun J, Győrffy B, Hardiman KM (2016) HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling. Oncotarget. 7(10):11567–11579PubMedPubMedCentral Xue X, Jungles K, Onder G, Samhoun J, Győrffy B, Hardiman KM (2016) HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling. Oncotarget. 7(10):11567–11579PubMedPubMedCentral
85.
go back to reference Nishimoto A, Kugimiya N, Hosoyama T, Enoki T, Li TS, Hamano K (2014) HIF-1α activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells. Int J Oncol 44(6):2077–2084PubMed Nishimoto A, Kugimiya N, Hosoyama T, Enoki T, Li TS, Hamano K (2014) HIF-1α activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells. Int J Oncol 44(6):2077–2084PubMed
86.
go back to reference Tripathi A, Melnik AV, Xue J et al (2018) Intermittent hypoxia and hypercapnia, a hallmark of obstructive sleep apnea, alters the gut microbiome and metabolome. mSystems 3(3) Tripathi A, Melnik AV, Xue J et al (2018) Intermittent hypoxia and hypercapnia, a hallmark of obstructive sleep apnea, alters the gut microbiome and metabolome. mSystems 3(3)
87.
go back to reference Moreno-Indias I, Torres M, Montserrat JM et al (2015) Intermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea. Eur Respir J 45(4):1055–1065PubMed Moreno-Indias I, Torres M, Montserrat JM et al (2015) Intermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea. Eur Respir J 45(4):1055–1065PubMed
88.
go back to reference Ko CY, Hu AK, Chou D et al (2019) Analysis of oral microbiota in patients with obstructive sleep apnea-associated hypertension. Hypertens Res Ko CY, Hu AK, Chou D et al (2019) Analysis of oral microbiota in patients with obstructive sleep apnea-associated hypertension. Hypertens Res
89.
go back to reference Lu D, Yao X, Abulimiti A et al (2018) Profiling of lung microbiota in the patients with obstructive sleep apnea. Medicine (Baltimore) 97(26):e11175 Lu D, Yao X, Abulimiti A et al (2018) Profiling of lung microbiota in the patients with obstructive sleep apnea. Medicine (Baltimore) 97(26):e11175
90.
go back to reference Durgan DJ, Ganesh BP, Cope JL et al (2016) Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension. 67(2):469–474PubMed Durgan DJ, Ganesh BP, Cope JL et al (2016) Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension. 67(2):469–474PubMed
91.
go back to reference Durgan DJ (2017) Obstructive sleep apnea-induced hypertension: role of the gut microbiota. Curr Hypertens Rep 19(4):35PubMed Durgan DJ (2017) Obstructive sleep apnea-induced hypertension: role of the gut microbiota. Curr Hypertens Rep 19(4):35PubMed
92.
go back to reference Moreno-Indias I, Torres M, Sanchez-Alcoholado L et al (2016) Normoxic recovery mimicking treatment of sleep apnea does not reverse intermittent hypoxia-induced bacterial dysbiosis and low-grade endotoxemia in mice. Sleep. 39(10):1891–1897PubMedPubMedCentral Moreno-Indias I, Torres M, Sanchez-Alcoholado L et al (2016) Normoxic recovery mimicking treatment of sleep apnea does not reverse intermittent hypoxia-induced bacterial dysbiosis and low-grade endotoxemia in mice. Sleep. 39(10):1891–1897PubMedPubMedCentral
93.
go back to reference Ko CY, Fan JM, Hu AK et al (2019) Disruption of sleep architecture in Prevotella enterotype of patients with obstructive sleep apnea-hypopnea syndrome. Brain Behav:e01287 Ko CY, Fan JM, Hu AK et al (2019) Disruption of sleep architecture in Prevotella enterotype of patients with obstructive sleep apnea-hypopnea syndrome. Brain Behav:e01287
94.
go back to reference Ohigashi S, Sudo K, Kobayashi D et al (2013) Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig Dis Sci 58(6):1717–1726PubMed Ohigashi S, Sudo K, Kobayashi D et al (2013) Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig Dis Sci 58(6):1717–1726PubMed
95.
go back to reference Chen HM, Yu YN, Wang JL et al (2013) Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr 97(5):1044–1052PubMed Chen HM, Yu YN, Wang JL et al (2013) Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr 97(5):1044–1052PubMed
96.
go back to reference Payne AN, Chassard C, Lacroix C (2012) Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev 13(9):799–809PubMed Payne AN, Chassard C, Lacroix C (2012) Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev 13(9):799–809PubMed
97.
98.
go back to reference Huycke MM, Gaskins HR (2004) Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 229(7):586–597 Huycke MM, Gaskins HR (2004) Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 229(7):586–597
99.
go back to reference Muyzer G, Stams AJ (2008) The ecology and biotechnology of sulphate-reducing bacteria. Nat Rev Microbiol 6(6):441–454PubMed Muyzer G, Stams AJ (2008) The ecology and biotechnology of sulphate-reducing bacteria. Nat Rev Microbiol 6(6):441–454PubMed
108.
go back to reference Campos-Rodriguez F, Asensio-Cruz MI, Cordero-Guevara J et al (2019) Effect of continuous positive airway pressure on inflammatory, antioxidant, and depression biomarkers in women with obstructive sleep apnea: a randomized controlled trial. Sleep 42(10). https://doi.org/10.1093/sleep/zsz145 Campos-Rodriguez F, Asensio-Cruz MI, Cordero-Guevara J et al (2019) Effect of continuous positive airway pressure on inflammatory, antioxidant, and depression biomarkers in women with obstructive sleep apnea: a randomized controlled trial. Sleep 42(10). https://​doi.​org/​10.​1093/​sleep/​zsz145
Metadata
Title
The effect of intermittent hypoxia and fecal microbiota of OSAS on genes associated with colorectal cancer
Authors
Jia Gao
Hailong Cao
Qiang Zhang
Bangmao Wang
Publication date
01-06-2021
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 2/2021
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-020-02204-z

Other articles of this Issue 2/2021

Sleep and Breathing 2/2021 Go to the issue

Sleep Breathing Physiology and Disorders • Short Communication

Extreme sports performance for more than a week with severely fractured sleep

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.